The Annals recently advertised for a contributing writer for the NerveCenter section. One applicant listed ghostwriting as her major accomplishment, and proudly provided a list of selected, unattributed manuscripts illustrating her work…
Filed under: Message From the Editor | Tagged: Annals of Neurology, FDA, ghostwriting, pharmaceutical industry | Leave a Comment »
